Annual report pursuant to Section 13 and 15(d)

Income Tax (Details)

v3.21.1
Income Tax (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Tax    
Unrecognized tax benefit $ 0 $ 0
Unrecognized income tax benefits impact on effective income tax rate 0 0
Accrual for interest and penalties relating to uncertain income tax positions $ 0 0
Statutory federal tax rate 21.00%  
Valuation allowance $ 32,484,566 26,793,281
State Net Operating Loss Carryforwards    
Income Tax    
Net operating loss carryforwards   $ 103,538,617
Net operating loss carryforwards expiration dates   Dec. 31, 2024
Federal Net Operating Loss Carryforwards    
Income Tax    
Net operating loss carryforwards   $ 118,799,856
Net operating loss carryforwards expiration dates   Dec. 31, 2029
Pelican Therapeutics    
Income Tax    
Net operating loss carryforwards   $ 3,027,284
State Net Pelican Therapeutics    
Income Tax    
Net operating loss carryforwards   2,464,819
Foreign Net Operating Loss Carryforwards    
Income Tax    
Net operating loss carryforwards   127,610
Pelican Net Operating Loss Carryforwards    
Income Tax    
Net operating loss carryforwards   $ 2,416,776